185 related articles for article (PubMed ID: 17088249)
1. LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-kappaB activation.
Wullaert A; Verstrepen L; Van Huffel S; Adib-Conquy M; Cornelis S; Kreike M; Haegman M; El Bakkouri K; Sanders M; Verhelst K; Carpentier I; Cavaillon JM; Heyninck K; Beyaert R
J Biol Chem; 2007 Jan; 282(1):81-90. PubMed ID: 17088249
[TBL] [Abstract][Full Text] [Related]
2. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.
Verstrepen L; Carpentier I; Verhelst K; Beyaert R
Biochem Pharmacol; 2009 Jul; 78(2):105-14. PubMed ID: 19464428
[TBL] [Abstract][Full Text] [Related]
3. The biology of A20-binding inhibitors of NF-kappaB activation (ABINs).
Verstrepen L; Carpentier I; Beyaert R
Adv Exp Med Biol; 2014; 809():13-31. PubMed ID: 25302363
[TBL] [Abstract][Full Text] [Related]
4. Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaB.
Verstrepen L; Adib-Conquy M; Kreike M; Carpentier I; Adrie C; Cavaillon JM; Beyaert R
J Cell Mol Med; 2008; 12(1):316-29. PubMed ID: 18081698
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2.
Van Huffel S; Delaei F; Heyninck K; De Valck D; Beyaert R
J Biol Chem; 2001 Aug; 276(32):30216-23. PubMed ID: 11390377
[TBL] [Abstract][Full Text] [Related]
6. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
[TBL] [Abstract][Full Text] [Related]
7. ABIN-3: a molecular basis for species divergence in interleukin-10-induced anti-inflammatory actions.
Weaver BK; Bohn E; Judd BA; Gil MP; Schreiber RD
Mol Cell Biol; 2007 Jul; 27(13):4603-16. PubMed ID: 17485448
[TBL] [Abstract][Full Text] [Related]
8. A20 inhibits toll-like receptor 2- and 4-mediated interleukin-8 synthesis in airway epithelial cells.
Gon Y; Asai Y; Hashimoto S; Mizumura K; Jibiki I; Machino T; Ra C; Horie T
Am J Respir Cell Mol Biol; 2004 Sep; 31(3):330-6. PubMed ID: 15142865
[TBL] [Abstract][Full Text] [Related]
9. ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB.
Mauro C; Pacifico F; Lavorgna A; Mellone S; Iannetti A; Acquaviva R; Formisano S; Vito P; Leonardi A
J Biol Chem; 2006 Jul; 281(27):18482-8. PubMed ID: 16684768
[TBL] [Abstract][Full Text] [Related]
10. Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1.
Heyninck K; Kreike MM; Beyaert R
FEBS Lett; 2003 Feb; 536(1-3):135-40. PubMed ID: 12586352
[TBL] [Abstract][Full Text] [Related]
11. ABIN-1 protects chondrocytes from lipopolysaccharide-induced inflammatory injury through the inactivation of NF-κB signalling.
Peng K; Li Y; Lu C; Hu S
Clin Exp Pharmacol Physiol; 2020 Jul; 47(7):1212-1220. PubMed ID: 32100889
[TBL] [Abstract][Full Text] [Related]
12. FLN29, a novel interferon- and LPS-inducible gene acting as a negative regulator of toll-like receptor signaling.
Mashima R; Saeki K; Aki D; Minoda Y; Takaki H; Sanada T; Kobayashi T; Aburatani H; Yamanashi Y; Yoshimura A
J Biol Chem; 2005 Dec; 280(50):41289-97. PubMed ID: 16221674
[TBL] [Abstract][Full Text] [Related]
13. Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulation.
Verhelst K; Verstrepen L; Coornaert B; Carpentier I; Beyaert R
Methods Mol Biol; 2009; 517():205-15. PubMed ID: 19378032
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of ABIN-2, a negative regulator of NF-kappaB, delays liver regeneration in the ABIN-2 transgenic mice.
Li CC; Chou CK; Wang MH; Tsai TF
Biochem Biophys Res Commun; 2006 Mar; 342(1):300-9. PubMed ID: 16480954
[TBL] [Abstract][Full Text] [Related]
15. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes.
Zhang FX; Kirschning CJ; Mancinelli R; Xu XP; Jin Y; Faure E; Mantovani A; Rothe M; Muzio M; Arditi M
J Biol Chem; 1999 Mar; 274(12):7611-4. PubMed ID: 10075645
[TBL] [Abstract][Full Text] [Related]
16. ABINs inhibit EGF receptor-mediated NF-kappaB activation and growth of EGF receptor-overexpressing tumour cells.
Huang L; Verstrepen L; Heyninck K; Wullaert A; Revets H; De Baetselier P; Beyaert R
Oncogene; 2008 Oct; 27(47):6131-40. PubMed ID: 18622428
[TBL] [Abstract][Full Text] [Related]
17. The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosis.
Liu WK; Yen PF; Chien CY; Fann MJ; Su JY; Chou CK
Biochem J; 2004 Mar; 378(Pt 3):867-76. PubMed ID: 14653779
[TBL] [Abstract][Full Text] [Related]
18. A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells.
Yin H; Karayel O; Chao YY; Seeholzer T; Hamp I; Plettenburg O; Gehring T; Zielinski C; Mann M; Krappmann D
Cell Mol Life Sci; 2022 Jan; 79(2):112. PubMed ID: 35099607
[TBL] [Abstract][Full Text] [Related]
19. A20-binding inhibitor of nuclear factor-kappaB (NF-kappaB)-2 (ABIN-2) is an activator of inhibitor of NF-kappaB (IkappaB) kinase alpha (IKKalpha)-mediated NF-kappaB transcriptional activity.
Leotoing L; Chereau F; Baron S; Hube F; Valencia HJ; Bordereaux D; Demmers JA; Strouboulis J; Baud V
J Biol Chem; 2011 Sep; 286(37):32277-88. PubMed ID: 21784860
[TBL] [Abstract][Full Text] [Related]
20. Functional redundancy of the zinc fingers of A20 for inhibition of NF-kappaB activation and protein-protein interactions.
Klinkenberg M; Van Huffel S; Heyninck K; Beyaert R
FEBS Lett; 2001 Jun; 498(1):93-7. PubMed ID: 11389905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
